Integrative transcriptomics reveals sexually dimorphic control of the cholinergic/neurokine interface in schizophrenia and bipolar disorder

Keyphrases

• Schizophrenia Symptoms 100%
• Bipolar Disorder 100%
• Sex-specific Differences 100%
• Transcriptomics 100%
• Sexually Dimorphic 100%
• Sex-related Differences 100%
• Neurokine 100%
• Immunology 50%
• Data Combination 50%
• Neuroinflammation 50%
• Therapeutic Intervention 50%
• Autism Spectrum Disorder 50%
• Cell Biology 50%
• Molecular Mechanism 50%
• Schizophrenia 50%
• Prognostic Implications 50%
• Mental Health 50%
• Disease Onset 50%
• Delayed Diagnosis 50%
• Disease Development 50%
• RNA-seq Analysis 50%
• Sex Differences 50%
• New Dataset 50%
• Therapeutic Implications 50%
• Biology Study 50%
• Innovative Solutions 50%
• Mental Impairment 50%
• Molecular Player 50%
• Neurogenetics 50%
• Psychological Stressors 50%
• Neuroendocrinology 50%
• Environmental Susceptibility 50%
• Viral Exposure 50%
• Neuropsychopharmacology 50%
• Targeted Diagnosis 50%
• Molecular Psychiatry 50%

Neuroscience

• Cholinergic 100%
• Bipolar Disorder 100%
• Transcriptomics 100%
• Pervasive Developmental Disorder 50%
• RNA Sequence 50%
• Psychiatry 50%
• Psychopharmacology 50%
• Neuroendocrinology 50%